<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        10-666-20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2021
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        HIDRASEC
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        RACECADOTRIL
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        100
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Capsule, hard
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        21.19
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Laboratoires SOPHARTEX" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Laboratoires SOPHARTEX
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 360]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Farouk, Maamoun Tamer & CO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Abbott Laboratories GmbH
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A07XA04
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Pharmacotherapeutic group &ndash; ATC code: A07XA04 (A: digestive system and metabolism)<br />This medicine is an anti-diarrhoeal product.<br />This medicine is indicated for the symptomatic treatment of acute diarrhoea in adults in addition to dietary measures.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Hidrasec 100 mg, capsule:</strong><br />If you are allergic (hypersensitive) to the active substance or any of the other ingredients of this medicine listed<br />in section 6.<br /><strong>Warnings and precautions</strong><br />Diarrhoea leads to the loss of fluids and mineral salts.<br />This treatment is a supplement to the following dietary measures:<br />&bull; Rehydrate by drinking large quantities of sweet or savoury drinks to off-set fluid loss due to<br />diarrhoea (the average daily water intake for adults is 2 litres).<br />&bull; Continue to eat despite having diarrhoea:<br />Avoid certain foods and drinks especially salad, fruit, green vegetables, spicy dishes and frozen/chilled food or drinks.<br />Opt instead for grilled meats and rice.<br /><u>Precautions for use:</u><br />You must seek medical advice if:<br />&bull; You notice blood or mucus in your stools and your temperature rises<br />&bull; You experience diarrhoea while taking a broad-spectrum antibiotic</p><p>&bull; You have renal or liver impairment<br />&bull; In the case of prolonged or uncontrolled vomiting.<br /><strong>Warnings:</strong><br />This medicine is not suitable for children.<br />Cases of hypersensitivity and Quincke&rsquo;s oedema (swelling) have been reported in patients treated with racecadotril<br />(the active substance contained in this medicine). Angioedema of the face, limbs, lips and mucosa, etc., or swelling of<br />the upper airways such as the tongue, glottis and/or larynx may occur at any time during treatment.<br />If you experience any of these adverse effects, stop taking the treatment immediately and contact your doctor.<br />Patients with a history of angioedema (swelling) not related to racecadotril treatment may be at increased risk of<br />developing angioedema.<br />The concomitant use of racecadotril and other medicines may increase the risk of angioedema (see the section &ldquo;Other<br />medicines and Hidrasec 100 mg, capsule&rdquo;).<br />Skin reactions have been reported following administration of this medicine. These reactions are mostly mild to<br />moderate. In the event of severe skin reactions, racecadotril treatment must be stopped immediately and medical<br />advice should be sought. Racecadotril must not be reintroduced</p><p><strong>Children and adolescents</strong><br />Not applicable.<br /><strong>Other medicines and Hidrasec 100 mg capsule</strong><br />Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicine, especially:<br />- An angiotensin converting enzyme inhibitor (e.g.: perindopril or ramipril) to lower blood pressure and help the heart<br />to function properly.<br />- Angiotensin II antagonists (e.g.: candesartan or irbesartan) to treat high blood pressure and heart failure.<br /><strong>Hidrasec 100 mg, capsule with food, drink and alcohol</strong><br />Not applicable.<br /><strong>Pregnancy, breast-feeding and fertility</strong><br />Ask your doctor or pharmacist for advice before taking any medicine<br /><strong>Pregnancy</strong><br />Given the data available, it is preferable to exercise caution and avoid using racecadotril during pregnancy, regardless<br />of trimester.<br /><strong>Breast-feeding</strong><br />This medicine must not be administered during breast-feeding given the lack of information on the diffusion of the<br />active substance in human milk.<br /><strong>Driving and using machines</strong><br />Hidrasec 100 mg, capsule, has no effect or a negligible effect on the ability to drive and use machines.<br /><strong>Hidrasec 100 mg, capsule contains lactose.</strong><br />If your doctor has told you that you are intolerant to certain sugars, talk to him/her before taking this medicine.<br />This medicine does not contain gluten.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>3. How to take Hidrasec 100 mg, capsule</strong></p><p>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or<br />pharmacist if you are not sure.<br /><strong>Dosage</strong><br />Day 1: the first capsule, at whatever time, then, depending on the time of the first dose, up to a<br />maximum of three capsules in divided doses throughout the day, including the initial dose. The doses<br />should preferably be taken at the start of the three main meals.<br />On the following days: three divided daily doses, preferably at the start of the three main meals.<br />Not more than three doses may be taken per day.<br />Hidrasec is available in other pharmaceutical forms for use in children and infants.<br />No dose adjustment is required in elderly subjects.<br />Always take strictly as prescribed.<br /><strong>Method of treatment</strong><br />Oral route. Swallow with a glass of water.<br /><strong>Duration of treatment</strong><br />Treatment will be continued up until the first two solid stools have been passed in succession.<br />Do not take for more than 7 days.<br /><strong>If you take more Hidrasec 100 mg, capsule than you should</strong><br />Contact your doctor or pharmacist immediately.<br /><strong>If you forget to take Hidrasec 100 mg, capsule</strong><br />Do not take a double dose to make up for a forgotten dose.<br />Continue with the next dose.<br /><strong>If you stop taking Hidrasec 100 mg, capsule</strong><br />Not applicable.<br />Contact your doctor or pharmacist if you have any further questions regarding the use of this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.<br />You must stop taking Hidrasec 100 mg, capsule and seek medical advice immediately if you experience any<br />symptoms of angioedema such as:<br />&bull; Swelling of the face, tongue or throat<br />&bull; Swallowing difficulties<br />&bull; Nettle rash (urticaria) and breathing difficulties.<br /><strong>Common side effects</strong> (may affect at least 1 patient in 100 but fewer than 1 in 10): headache<br /><strong>Uncommon side effects </strong>(may affect at least 1 in 1,000 patients but fewer than 1 in 100 patients): Skin<br />rash and erythema (redness of the skin)<br /><strong>Frequency not known</strong> (cannot be estimated from the available data):<br />Erythema multiforme (pinkish lesions on the limbs and in the mouth), oedema of the tongue, lips, eyelids and<br />face, angioedema (sub-cutaneous inflammation affecting various parts of the body), urticaria, erythema&nbsp;nodosum (inflammation in the form of a nodule beneath the skin), papular rash (skin rash in the form of small,<br />hard, pustular lesions), pruritus (itching affecting the entire body), prurigo (skin lesions causing itching), drug<br />eruption.<br /><strong>Reporting side effects</strong><br />If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in<br />this leaflet.<br />By reporting side effects, you can help provide more information on the safety of this medicine.<br />To report any side effect(s):<br />&bull; National Pharmacovigilance Center (NPC)<br />&bull; Fax: +966-1-205-7662<br />&bull; Call NPC: 1999<br />&bull; E-mail: npc.drug@sfda.gov.sa<br />&bull; Website: https://ade.sfda.gov.sa</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull; Keep this medicine out of the sight and reach of children.<br />&bull; Do not use this medicine after the expiry date which is stated on the carton after &ldquo;do not use<br />after&rdquo; or &ldquo;exp&rdquo;. The expiry date refers to the last day of that month.<br />&bull; Store at temperature below 30◦C.<br />&bull; Store in the original packaging.<br />&bull; Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how<br />to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull; The active substance is:<br />Racecadotril &hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;. 100 mg<br />For one capsule<br />&bull; The other ingredients are:<br />Lactose monohydrate, pregelatinised maize starch, magnesium stearate, anhydrous colloidal silica.<br />Composition of the capsule shell: gelatine, titanium dioxide (E171), yellow iron oxide (E172).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This medicine is available as an ivory capsule containing a white powder with the odour of sulphur.
Boxes of 10 capsules.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorisation Holder</strong></p><p>Abbott Laboratories GmbH, Freundallee 9A, 30173 Hannover, Germany&nbsp;</p><p><strong>Manufacturer&nbsp;</strong></p><p>Sophartex, 21 Rue du pressoir, 28500 Vernouillet, France</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                04/2023 
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>الفئة الدوائية العلاجية - : رمز التصنيف الكيميائي&nbsp; العلاجي التشريحي<br />A)A07XA04 :&nbsp;الجهاز الهضمي والتمثيل الغذائي&nbsp;<br /><br />هذا الدواء منتج مضاد للإسهال.<br />يُقصد استعمال هذا الدواء لعلاج أعراض الإسهال الحاد مع البالغين، بالإضافة إل التدابير&nbsp;الغذائية</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تتناول كبسولات هيدراسيك 100ملجم في الحالات التالية</strong><strong>:</strong><br /><br />إن كنت مصابًا بالحساسية )فرط التحسس<br /><br />. تجاه المادة الفعالة أو أي من المكونات الأخرى للدواء المذكورة في( القسم&nbsp;6)<br /><strong>تحذيرات واحتياطات</strong><br />يؤدي الإسهال إلى فقدان السوائل والأملاح المعدنية.<br />وهذا العلاج يكمل التدابير الغذائية التالية:<br />&bull; داوم على ترطيب جسمك عن طريق تناول كميات كبيرة من المشروبات السُكرية أو المالحة لتعويض السوائل المفقودة بسبب الإسهال (متوسط ماينبغي<br />للشخص البالغ تناوله يوميًا لتران )&nbsp;<br /><br />&bull; داوم على تناول الطعام رغم الإصابة بالإسهال.<br />ا<br />تجنب أطعمة ومشروبات&nbsp;معينة، خاصة السلطة والفاكهة والخضروات الخضراء&nbsp;والأطباق الحارة والأطعمة أو المشروبات &nbsp;المجمدة&nbsp;<br />اختر&nbsp; بدل من ذلك اللحوم المشوية والأرز.<br /><strong>احتياطات الاستخدام</strong><strong>:</strong></p><p dir="RTL">يجب أن تطلب المشورة الطبية إن&nbsp;</p><p dir="RTL">&bull;&nbsp;لاحظت دمًا او مخاطا في&nbsp;برازك وإن ارتفعت درجة حرارتك</p><p dir="RTL">&bull;&nbsp;أصبت بإسهال أثناء تناول مضاد حيوي واسع المجال<br />&bull; أصبت بقصور كلوي أو كبدي</p><p dir="RTL">&bull; في حالة القيء المطول او غير المنضبط&nbsp;</p><p dir="RTL"><strong>التحذيرات</strong>:</p><p>هذا الدواء غير مناسب للأطفال.<br />تم الإبلاغ عن حالات فرط الحساسية وذمة كوينك (تورم) لدى المر&nbsp;ضى الذين عولجوا براسيكادوتريل(المادة الفعالة الموجودة في هذا الدواء). قد<br />تحدث&nbsp;وذمة وعائية في الوجه والأطراف والشفتين&nbsp;والغشاء المخاطي وما الى ذلك، أو تورم في الشعب الهوائية العلوية مثل اللسان و/أو المزمار و/أو&nbsp;الحنجرة في&nbsp;<br />أي وقت أثناء العلاج.<br />إذا واجهت أيًا من هذه الآثار الضارة، توقف عن تناول العلاج فورًا واتصل بطبيبك<br />المرضى الذين لديهم تاريخ من الوذمة الوعائية (التورم) غير المرتبطة بعلاج راسيكادوتريل قد يكونون أكثر عرضة للإصابة بالوذمة الوعائية.<br />قد يؤدي الاستخدام المتزامن لراسيكادوتريل مع أدوية أخرى إل زيادة خطر الوذمة الوعائية )انظر قسم &ldquo;الأدوية الأخرى وهيدراسيك 100 ملجم،<br />كبسولة&rdquo;.<br />تم الإبلاغ عن تفاعلات جلدية بعد تناول هذا الدواء.&nbsp;ردود الفعل&nbsp;هذه في&nbsp;الغالب خفيفة إل معتدلة .في&nbsp;حالة حدوث تفاعلات جلدية شديدة، يجب<br />إيقاف علاج راسيكادوتريل فورًا وطلب المشورة الطبية. لا يجوز إعادة تقديم راسيكادوتريل.</p><p dir="RTL"><strong>الأطفال والمراهقون</strong><br />لا تنطبق.<br /><strong>الأدوية الأخرى وكبسولات هيدراسيك 100 ملجم</strong><br />أبلغ الطبيب أو الصيدلي اإن كنت تتناول، أو سبق لك تناول، أو قد تتناول أي أدوية أخرى، خاصة:<br />- مثبط الإنزيم المحول للأنجيوتتسين )مثل ب رييندوبريل أو رامييريل ( لخفض ضغط الدم ومساعدة القلب على أداء وظائفه بشكل صحيح<br />- مضادات للأنجيوتتسين 2 (مثل: كانديسارتان أو إربيسارتان) لعلاج ارتفاع ضغط الدم وفشل القلب</p><p dir="RTL"><strong>كبسولات هيدراسيك 100 ملجم مع الطعام والشراب والكحول</strong></p><p dir="RTL">لا تنطبق.<br /><strong>الحمل والرضاعة الطبيعية والخصوبة</strong><br />استشر طبيبكِ أو الصيدلي&nbsp;&nbsp;قبل تناول أي دواء.<br />ا<strong>لحمل</strong><br />بالنظر للبيانات المتاحة، يستحسن أن تتخذي حذرك وتتجنبي&nbsp;استخدام راسيكادوتريل أثناء الحمل، بصرف النظر عن شهور الحمل.<br /><strong>الرضاعة الطبيعية</strong><br />يجب عدم إعطاء هذا الدواء أثناء الرضاعة الطبيعية بالنظر إلى نقص المعلومات بشأن تسرب المادة الفعالة إلى الحليب البشري .<br /><strong>القيادة واستخدام الآلات</strong><br />ليس لكبسولات هيدراسيك 100 ملجم تأثير &nbsp;أو له تأثير&nbsp;لا يُذكر على إمكانية القيادة واستخدام الماكينات.<br /><strong>تحتوي كبسولات هيدراسيك 100 ملجم على اللاكتوز</strong><br />إذا أخبرك&nbsp;طبيبك أنك لا تتحمل بعض السكريات، فاستشره قبل تناول هذا الدواء.<br />لا يحتوي هذا الدواء على الجلوتين&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تناول دومًا هذا الدواء بالطريقة التي&nbsp;حددها لك الطبيب أو الصيدلي. وراجع الطبيب أو الصيدلي&nbsp;إن كنت في شك من أمرك&nbsp;</p><p dir="RTL"><strong>الجرعة&nbsp;</strong></p><p dir="RTL">اليوم الأول: تناول الكبسولة الأولى في اي وقت,&nbsp;ثم، حسب وقت الجرعة الأول، تناول ما لا&nbsp;يزيد عن ثلاث كبسولات مقسمة إلى&nbsp;جرعات على مدار اليوم , بما في ذلك الجرعة المبدئية .&nbsp;ويستحسن تناول الجرعات في&nbsp;بداية الوجبات الثلاثة الرئيسية&nbsp;<br />في الأيام التالية: تناول ثلاث جرعات مقسمة يوميًا، ويستحسن أن يكون ذلك في بداية الوجبات الثلاثة الرئيسية .</p><p dir="RTL">لا ينبغي تناول اكثر&nbsp; من ثلاث جرعات في اليوم.<br />يتوفر هيدراسيك في&nbsp;أشكال دوائية أخرى للاستخدام&nbsp;الأطفال والرُضع.<br />لا دا عي لضبط الجرعة في المسنين&nbsp;<br />تناوله دومًا حسب تعليمات وصف الدواء بالضبط</p><p dir="RTL"><strong>طريقة العلاج</strong><br />عن طريق الفم، ويُبلع مع كوب ماء</p><p dir="RTL"><strong>مدة العلاج</strong><br />سيستمر العلاج حتى يتغوط المريض مرتين برازا صلبًا على التوالي.<br />لا تتناوله لأكثر من 7 أيام.</p><p dir="RTL"><strong>في حالة تناولك جرعة أكبر مما ينبغي من كبسولات هيدراسيك&nbsp;</strong><strong>100 ملجم</strong><br />أخبر&nbsp;طبيبك أو الصيدلي فورًا.<br /><strong>في حالة نسيانك تناول كبسولات هيدراسيك 100 ملجم&nbsp;</strong><br />لا تتناول جرعة مزدوجة لتعويض الجرعة المنسية. والتزم&nbsp;بتناول الجرعة التالية.<br /><strong>إذا توقفت عن تناول كبسولات هيدراسيك 100 ملجم</strong><br />لا تنطبق.<br />اتصل بالطبيب أو الصيدلي إذا كان لديك أي أسئلة أخرى متعلقة باستعمال هذا الدواء</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يمكن أن يتسبب هذا الدواء مثل جميع الأدوية في حدوث اثار جانبية ,&nbsp;على الرغم من عدم تعرض جميع المرضى&nbsp;لها.<br />يجب أن توقف تناول كبسولات هيدراسيك 100 ملجم وتطلب المشورة الطبية فورًا إن أصبت بأي أعراض للوذمة الوعائية، ومنها:<br />&bull; تورم الوجه أو اللسان أو الحلق<br />&bull; صعوبات البلع<br />&bull; الحمى القراصية (الأرتيكاريا)وصعوبات التنفس<br /><strong>آثار جانبية شائعة</strong> (&nbsp;قد تصيب مريض واحدا على الاقل من كل&nbsp;100 ولكن معدل حدوثها أقل من 1 من 10 ): الصداع<br /><br /><strong>آثار جانبية غير شائعة</strong> (قد تصيب مريض واحدا على الاقل من كل 1000 ، ولكن معدل حدوثها أقل من 1 من 100 ): الطفح&nbsp;الجلدي&nbsp;<br />والحُمامى (احمرار الجلد)<br /><strong>آثار جانبية غير&nbsp;معلومة</strong> (يتعذر تقدير معدل تكرارها من البيانات المتاحة):<br /><br />الحُمامى متعدد الأشكال (آفات وردية في&nbsp;الأطراف والفم ),&nbsp;ووذمة في اللسان والشفتين&nbsp;والجفنين&nbsp; والوجه,&nbsp;&nbsp;والوذمة الوعائية (التهاب تحت&nbsp;الجلد يؤثر على أجزاء مختلفة من الجسم(، والأرتيكاريا، والحُمامى العقدي )التهاب في شكل عقدة تحت الجلد، والطفح الجلدي الحطاطي (طفح جلدي في&nbsp;شكل آفات بثرانية صغيرة وصلبة(، والحكة )الهرش الذي يصيب الجسم بالكامل(، والحكاك )آفات جلدية تسبب الهرش(، والطفح&nbsp;الجلدي.</p><p dir="RTL">الإبلاغ عن الآثار الجانبية<br />إن أصبت بأي آثار جانبية، فاستشر الطبيب أو الصيدلي.&nbsp;يتضمن ذلك أي آثار جانبية محتملة غير مذكورة في هذه النشره&nbsp;.&nbsp;<br />بإبلاغك عن الآثار الجانبية، يمكنك المساعدة في توفير&nbsp;المزيد من المعلومات حول سلامة هذا الدواء.<br />للإبلاغ عن الأعراض الجانبية</p><p dir="RTL"><br />‫- &nbsp;المركز الوطني للتيقظ والسلامة الدوائية )NPC(<br />‫o فاكس 7662-205-11-966+ o مركز الاتصال: 19999<br />npc.drug@sfda.gov.sa :البريد الإلكتروني o<br />https://ade.sfda.gov.sa :الموقع الإلكتروني</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يحفظ هذا الدواء بعيدا عن متناول الأطفال ونطاق رؤيتهم.<br />ً<br /><br />&bull; لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المذكور على العبوة الكرتونية بعد الاختصار&nbsp; .&quot;EXP&quot;&nbsp;و يشير&nbsp;تاريخ&nbsp;انتهاء الصلاحية إل آخر يوم في&nbsp;ذلك الشهر.<br />&bull; يحفظ في درجة حرارة&nbsp;أقل من&nbsp;30 درجة مئوية<br />&bull; يحفظ في العبوة الأصلية<br />&bull; ينبغي عدم التخلص من الأدوية عن طريق الصرف الصحي أو النفايات المنزلية. وعليك سؤال الصيدلي عن كيفية التخلص من الأدوية التي&nbsp;<br />لم تعد تستخدمها. وستساعد تلك الإجراءات على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">محتويات كبسولات هيدراسيك 100 ملجم<br />&bull; المادة الفعالة ه:<br />راسيكادوتريل &hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;. 100 ملجم<br />الكبسولة الواحدة<br />&bull; المكونات الأخرى هي:<br />، لاكتوز أحادي الهيدرات، نشا الذرة الذي تم تحويله مسبق الى جيلاتين , ستيارات المغنيسيوم، سيليكا&nbsp;غروية لامائية.<br />تركيب غلاف الكبسولة:الجيلاتين و ثاني&nbsp;أكسيد التيتانيوم (E171)&nbsp;وأكسيد الحديد الأصفر E172</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يتوفر هذا الدواء في شكل كبسولات عاجية تحتوي على مسحوق ابيض له رائحة الكبريت&nbsp;</p><p dir="RTL">تحتوي العلبة&nbsp;على 10 كبسولات&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مالك رخصة التسويق<br />Abbott Laboratories GmbH<br />Freundallee 9A<br />30173 هانوفر<br />ألمانيا</p><p dir="RTL">الجهة المصنعة<br />SOPHARTEX, 21 Rue du pressoir 28500 VERNOUILLET, France.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            04/2023 
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hidrasec 100 mg, capsule
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Racecadotril ........................................................................................................................................ 100 mg.
For one capsule.
Excipient with known effect: Each capsule contains 41 mg of lactose monohydrate.
For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Capsule
Size 2, ivory capsule containing a white powder with the odour of sulphur.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>a. Therapeutic indications</strong><br />Hidrasec is indicated in the symptomatic treatment of acute diarrhoea in adults in addition to dietary<br />measures.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Posology</strong><br />Oral administration.<br />For adults only.<br /><strong>Adults:</strong><br />Day 1: a starting dose, at any time, then, depending on the time of the first dose, up to a maximum of three<br />capsules in divided daily doses (including the first dose). Medication should preferably be administered at the<br />beginning of the three main meals.<br />Subsequent days: three capsules in divided daily doses, preferably at the beginning of the three main meals.<br />Not more than three capsules must be taken per day.<br />The treatment is to be continued until there is a return to two consecutive solid stools. Never take for longer than<br />7 days.<br /><strong>Specific populations:</strong><br /><strong>Paediatric population:</strong><br />Hidrasec 100 mg, capsule, must not be administered to infants and children.<br />Other pharmaceutical forms of Hidrasec are suitable for administration to the paediatric population.<br /><strong>Elderly population:</strong></p><p>Dose adjustment does not appear justified in elderly subjects (see section 5.2).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Hidrasec treatment does not dispense with rehydration, if required.<br />Racecadotril must not be used if the signs of acute dysenteric syndrome are present such as bloody stools or<br />fever.<br />Racecadotril has not been assessed and must not be used during antibiotic-related diarrhoea.<br />There is an inadequate amount of data on chronic diarrhoea with this medicinal product.<br />Bioavailability may be reduced in patients with prolonged vomiting.<br />Hepatic and renal impairment:<br />The data are limited in patients presenting hepatic or renal impairment., Caution should, therefore, be exercised<br />when treating these patients (see section 5.2).<br />Excipients:<br />Patients presenting galactose intolerance, total lactase deficiency or glucose and galactose malabsorption<br />syndrome (rare hereditary diseases) must not take this medicinal product.<br />Hypersensitivity:<br />Skin reactions have been reported with the use of this medicinal product. In the majority of cases, these reactions<br />are mild and do not require treatment. In some situations, however, these reactions can be severe and potentially<br />life-threatening. The link associated with the administration of racecadotril cannot be entirely ruled out. If<br />serious skin reactions appear, racecadotril treatment must be discontinued immediately.<br />Cases of hypersensitivity and Quincke&rsquo;s oedema have been reported in patients receiving racecadotril. These<br />events may occur at any time during treatment.<br />Angioedema of the face, extremities, lips and mucosa may appear.<br />Emergency treatment should be administered rapidly if the angioedema is associated with an upper respiratory<br />tract obstruction, e.g. in the region of the tongue, glottis, and/or larynx.<br />Racecadotril must be discontinued and the patient placed under close, appropriate medical supervision. This<br />should be continued until symptoms permanently disappear in the long-term. Racecadotril must not be<br />reintroduced.</p><p>Bradykinin-mediated angioedema:</p><p><br />Racecadotril or certain therapeutic classes are likely to trigger an angioedema-type vascular reaction of the<br />face and neck, resulting from inhibition of bradykinin degradation (see section 4.8).<br />Angioedema can sometimes have fatal consequences due to obstruction of the airways. It can occur<br />independently of the concomitant administration of these medicinal products in cases where the patient has<br />had previous exposure to one of the two protagonists. The history of onset of this effect should be investigated<br />and the need for this type of combination therapy assessed.</p><p>Concomitant administration of racecadotril with certain medicinal products increasing bradykinin levels,<br />especially angiotensin converting enzyme (ACE) inhibitors (e.g. perindopril and ramipril), increases the risk<br />of bradykinin-mediated angioedema (see section 4.5)<br />A rigorous assessment of the benefit/risk ratio is therefore required before introducing racecadotril treatment<br />to patients receiving angiotensin converting enzyme inhibitors (see section 4.5).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Association to be avoided:</strong><br /><strong>Medicinal products, bradykinin and angioedema</strong><br />Certain medicinal products or therapeutic classes are likely to trigger an angioedema-type vascular<br />reaction of the face and neck resulting from inhibition of bradykinin degradation. ACE inhibitors (e.g.<br />perindopril and ramipril) are most frequently involved and, to less of an extent, angiotensin II<br />antagonists (e.g.: candesartan, irbesartan), so-called mTORi (mammalian target of rapamaycin<br />inhibitor) immunosuppressants, gliptin class antidiabetic agents, racecadotril, estramustine, sacubitril<br />and alteplase recombinant.<br />Angioedema can sometimes have fatal consequences due to obstruction of the airways. It can occur<br />independently of the concomitant administration of these medicinal products in cases where the patient has<br />had previous exposure to one of the two protagonists. The history of onset of this effect should be investigated<br />and the need for this type of combination therapy assessed.<br /><strong>Association to be avoided (see also section 4.4)</strong><br />+ Other medicinal products posing a risk of bradykinin-mediated angioedema (see the Medicinal<br />products, bradykinin and angioedema section).<br /><strong>Others</strong><br />The concomitant administration of racecadotril with loperamide or nifuroxazide does not modify the<br />kinetic profile of racecadotril.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pregnancy</strong><br />Animal studies have not revealed any direct or indirect harmful toxic effect on reproduction. Clinical data on the<br />use of racecadotril during pregnancy are very sparse. Therefore, as a precautionary measure, Hidrasec should be<br />avoided during pregnancy, regardless of trimester.<br /><strong>Breast-feeding</strong><br />Given the lack of data regarding the diffusion of racecadotril into human milk, and because of its<br />pharmacological properties and the immaturity of the digestive tract in newborns, Hidrasec should not be<br />administered during breast-feeding.<br /><strong>Fertility</strong><br />No effect on fertility has been observed during fertility studies conducted in male and female rats.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Racecadotril has no effect or a negligible effect on the ability to drive and use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Clinical trials focusing on acute diarrhoea have provided data from 2,193 adults treated with racecadotril and<br />282 receiving placebo.<br />The adverse drug reactions listed below have been observed more frequently with racecadotril than with<br />placebo during clinical trials or were reported during the marketing period.<br />The adverse drug reactions are listed according to the main MedDRA system organ classes. Within each system<br />organ class, the adverse reactions are listed according to frequency. Within each frequency group, the adverse<br />reactions are listed in decreasing order of seriousness. The frequency of adverse reactions has been defined<br />according to the following convention: very common (&ge; 1/10), common (&ge; 1/100 to &lt;1/10), uncommon (&ge; 1/1,000<br />to &lt;1/100), rare (&ge; 1/10,000 to &lt;1/1,000), very rare (&lt;1/10,000), frequency not known (cannot be estimated on the<br />basis of the data available).</p><p>&nbsp;</p><table border="1" cellspacing="1" cellpadding="1" style="width:500px"><tbody><tr><td style="width:145px">System organ<br />class</td><td style="width:112px">Frequency</td><td style="width:241px">Adverse reaction</td></tr><tr><td style="width:145px">Central nervous<br />system disorders</td><td style="width:112px">Common</td><td style="width:241px">Headache&nbsp;</td></tr><tr><td style="width:145px">Skin and<br />subcutaneous tissue<br />disorders (see<br />section 4.4)</td><td style="width:112px"><p>Uncommon</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Frequency not known</p></td><td style="width:241px"><p>Rash, erythema</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Erythema multiforme, oedema of the tongue,<br />face, lips or eyelids, angioedema (Quincke&rsquo;s<br />oedema), urticaria, erythema nodosum, papular<br />rash, pruritus, prurigo, drug eruption</p></td></tr></tbody></table><p>&nbsp;</p><p>Reporting of suspected adverse reactions<br />Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows<br />continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked<br />to report any suspected adverse reactions via:<br />To report any side effect(s):<br />&bull; National Pharmacovigilance Center (NPC)<br />&bull; Fax: +966-1-205-7662<br />&bull; Call NPC: 1999<br />&bull; E-mail: npc.drug@sfda.gov.sa<br />&bull; Website: https://ade.sfda.gov.sa</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None of the patients presented any adverse reactions in the overdose cases reported to date.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pharmacotherapeutic class: OTHER ANTIDIARRHETIC (INTESTINAL ANTI-SECRETORY<br />MEDICATION).</strong><br /><strong>ATC code: A07XA04. (A: Digestive system and metabolism).</strong><br />Racecadotril is a prodrug which must be hydrolysed into its active metabolite, thiorphan, which is an<br />inhibitor of enkephalinase, an enzyme of the cellular membrane, present in different tissues including<br />the intestinal epithelium.<br />This enzyme contributes to the hydrolysis of exogenic and endogenic peptides, such as enkephalins.<br />Racecadotril therefore protects enkephalins against enzymatic degradation, thus prolonging their action on the<br />enkephalinergic synapses of the small intestine and reducing hypersecretion.<br />Racecadotril is a pure intestinal anti-secretory substance. It reduces the intestinal hypersecretion of water<br />and electrolytes induced by the cholera toxin or inflammation, without impacting basal secretion. It acts as<br />an anti-diarrhoeal agent without altering intestinal transit time.<br />Racecadotril does not cause abdominal flatulence. During clinical trials, secondary constipation was observed at<br />the same frequency in the racecadotril and placebo groups.<br />Only peripheral activity is observed following oral administration. There is no effect on the central nervous<br />system.<br />A randomised, cross-over clinical study has shown that racecadotril 100 mg administered at the therapeutic<br />dose (1 capsule) or a higher dose (4 capsules) did not prolong the QT/QTc interval in 56 healthy adult<br />volunteers (unlike the effect observed with moxifloxacin, used as a positive control).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Absorption:</strong><br />Racecadotril is rapidly absorbed following oral administration. Plasma enkephalinase activity occurs after<br />thirty minutes.<br />The bioavailability of racecadotril is not changed by food, but peak activity is delayed by approximately 1.5<br />hours.<br /><strong>Distribution:</strong><br />Following oral administration of 14C-labelled racecadotril to healthy volunteers, a 200-fold increase in<br />racecadotril concentrations was recorded in the plasma compared to the blood cells, and a 3-fold increase<br />in the plasma versus total blood volume. There is no significant binding to blood cells.<br />In the plasma, the mean apparent volume of distribution of 66.4 L/kg demonstrates moderate distribution of 14C<br />in the other tissues.<br />Ninety percent of the active metabolite of racecadotril, thiorphan, (RS)-N-(1-oxo-2-(mercaptomethyl)-3-<br />phenylpropyl) glycine, is bound to plasma proteins, mainly albumin.<br />The pharmacokinetic properties of racecadotril do not alter during repeated dosing or in elderly subjects.<br />The extent and duration of action of racecadotril are dose-dependent. Peak plasma enkephalinase concentrations<br />are reached approximately 2 hours post-dose, corresponding to 75% inhibition for the dose of 100 mg.<br />Plasma enkephalinase activity continues for around 8 hours following the administration of 100 mg.</p><p>&nbsp;</p><p><strong>Biotransformation:&nbsp;</strong></p><p>The biological half-life of racecadotril, determined on the basis of enkephalinase plasma inhibition, is 3<br />hours.<br />Racecadotril is rapidly hydrolysed into tiorfan (RS)-N-(1-oxo-2-(mercaptomethyl)-3-phenylpropyl) glycine, its<br />active metabolite, which itself transforms into inactive metabolites S-methylthiorphan sulfoxide, S methyl<br />tiorfan, 2-methane sulfinylmethyl propionic acid and 2-methylsulfanylmethyl propionic acid, which are all<br />formed following more than 10% systemic exposure to the parent molecule.<br />Other minor metabolites have also been detected and quantified in the urine and faecal matter.<br />Repeated dosing with racecadotril does not cause accumulation in the body.<br />The in-vitro data show that racecadotril/tiorfan and its four major inactive metabolites do not significantly<br />inhibit cytochrome CYP 3A4 isoforms, 2D6, 2C9, 1A2 and 2C19.<br />The in-vitro data show that racecadotril/tiorfan and its four major inactive metabolites do not significantly<br />induce CYP cytochrome isoforms (family 3A, 2A6, 2B6, 2C9/2C19, family 1A, 2E1) and the enzymes<br />which bind to glucuronyl transferase.<br />Racecadotril does not change the protein binding of products which are strongly bound to proteins, such as<br />tolbutamide, warfarin, niflumic acid, digoxin or phenytoin.<br />In patients with hepatic insufficiency (cirrhosis, Child-Pugh B), the metabolite&rsquo;s kinetic profile displays the<br />same Tmax and T1/2 values and lower Cmax (-65%) and area under the curve (-29%) compared to healthy<br />subjects.<br />In patients with severe renal insufficiency (creatinine clearance between 11 and 39 ml/min), the metabolite&rsquo;s<br />kinetic profile displays a lower Cmax (-49 %) and larger area under the curve (+15 %) and T1/2 compared to<br />healthy volunteers (creatinine clearance &gt; 70 ml/min).<br />The pharmacodynamic results obtained in the paediatric population are similar to those of the adult<br />population, with Cmax being reached 2.5 hours post-dose. There is no accumulation following<br />administration of repeated doses every 8 hours, for 7 days.<br /><strong>Elimination:</strong><br />Racecadotril is eliminated via its active and inactive metabolites. Elimination occurs primarily via the kidneys<br />(81.4%) and, to a lesser extent, in the faeces (about 8%). There is no significant elimination via the pulmonary<br />route (less than 1% of the dose).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Four-week chronic toxicity studies conducted in monkeys and dogs, which are beneficial for assessing the<br />duration of treatment in humans, did not highlight any effect at doses of up to 1,250 mg/kg/day and 200<br />mg/kg, which correspond to safety margins of 625 and 62, respectively (in relation to humans).<br />Racecadotril did not prove to be immunotoxic to mice treated for 1 month.<br />Longer exposure (one year) to monkeys revealed generalised infections and reduced antibody response on<br />vaccination (at a dose of 500 mg/kg/day) and no infection/immune suppression at 120 mg/kg/day.<br />Similarly, a few infectious/immune responses were noted in dogs receiving 200 mg/kg/day for 26 weeks.<br />The clinical significance is not known: see section 4.8.<br />No mutagenic or clastogenic effects of racecadotril were observed during standard in-vivo and in-vitro testing.<br />No carcinogenicity tests were conducted since treatment is administered short term.<br />Reproductive and development toxicity tests (pre-embryonic and fertility development, antenatal and postnatal<br />development, embryo-foetal development studies) have not revealed any racecadotril-specific effect.<br />Other preclinical effects (such as severe anaemia, probably aplastic, increased diuresis, ketonuria and<br />diarrhoea) were observed only after exposure sufficiently exceeding the maximum exposure in<br />humans. Their clinical significance is not known.<br />A toxicity study conducted in young rats did not reveal any evidence of a significant racecadotril-related effect<br />at doses up to 160 mg/kg/day, which is 35 times higher than the recommended paediatric dose (e.g. 4.5<br />mg/kg/day).<br />Despite immature renal function in children under 1 year old, higher levels of exposure are not expected in this<br />particular group.</p><p>No harmful effects on the central nervous system, cardiovascular system or respiratory function have<br />been highlighted in other pharmacology safety studies.<br />In animals, racecadotril potentiates the effect of butyl hyoscine on the intestinal tract and on the<br />anticonvulsant effect of phenytoin.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Lactose monohydrate, pregelatinised maize starch, magnesium stearate and colloidal anhydrous silica.<br />Composition of the capsule shell: gelatine, titanium dioxide (E171), yellow iron oxide (E172)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>N/A.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>This medicinal product does not require any special precautions for storage.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>20 capsules in heat-formed blister strips (PVC-PVDC/aluminium).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.<br />Any unused medicinal product or waste material should be disposed of in accordance with current legislation</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Abbott Laboratories GmbH, Freundallee 9A, 30173 Hannover, Germany
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                04/2023
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>